febuxostat has been researched along with Renal Insufficiency in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Hu, Y; Jiang, B; Lou, H; Ruan, Z; Xu, Y; Yang, D | 1 |
| Arai, H; Ishimaru, Y; Kitamura, M; Maeda, K; Matsumura, K; Mori, T; Nishino, T; Obata, Y; Sohara, E; Uchida, S; Umene, R; Uramatsu, T | 1 |
| Becker, MA; Hunt, BJ; Jackson, RL; MacDonald, PA | 1 |
| Araki, H; Chisaki, Y; Hira, D; Maegawa, H; Morita, SY; Noda, S; Terada, T; Uzu, T; Yano, Y | 1 |
| Carcedo, D; Díaz-Torné, C; Perez-Ruiz, F | 1 |
| Becker, MA; Gunawardhana, L; Hunt, B; MacDonald, P; Saag, KG; Whelton, A | 1 |
| Hayashi, T; Hiramitsu, S; Hisatome, I; Jinnouchi, H; Kakuda, H; Kawai, N; Kimura, K; Kojima, S; Matsui, K; Mori, H; Ogawa, H; Ohya, Y; Saito, Y; Sugawara, M; Tokutake, E; Uchiyama, K; Wakasa, Y; Waki, M; Yokota, N | 1 |
| Hosoya, T; Iwao, O; Ohno, I; Tatsuo, H | 1 |
| Hoshide, S; Hosoya, T; Ishikawa, T; Komoriya, K; Kubo, J; Ohno, I; Takahashi, Y; Tsuchimoto, M | 1 |
6 trial(s) available for febuxostat and Renal Insufficiency
| Article | Year |
|---|---|
Diabetes and gout: efficacy and safety of febuxostat and allopurinol.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Body Mass Index; Cohort Studies; Comorbidity; Diabetes Complications; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Intention to Treat Analysis; Kidney; Lost to Follow-Up; Male; Middle Aged; Obesity; Patient Dropouts; Renal Insufficiency; Thiazoles; Xanthine Oxidase; Young Adult | 2013 |
Population Pharmacokinetics and Therapeutic Efficacy of Febuxostat in Patients with Severe Renal Impairment.
Topics: Adult; Aged; Aged, 80 and over; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Renal Insufficiency; Retrospective Studies | 2015 |
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Febuxostat; Female; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Severity of Illness Index | 2016 |
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia.
Topics: Aged; Aged, 80 and over; Brain Diseases; Cardiovascular Diseases; Cause of Death; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Research Design; Single-Blind Method; Treatment Outcome; Uric Acid | 2017 |
A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study.
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Febuxostat; Female; Follow-Up Studies; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Oxypurinol; Renal Insufficiency; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase; Young Adult | 2011 |
PK/PD and safety of a single dose of TMX-67 (febuxostat) in subjects with mild and moderate renal impairment.
Topics: Area Under Curve; Enzyme Inhibitors; Febuxostat; Female; Humans; Kidney; Kidney Diseases; Male; Renal Insufficiency; Thiazoles; Time Factors; Xanthine Oxidase | 2004 |
3 other study(ies) available for febuxostat and Renal Insufficiency
| Article | Year |
|---|---|
Simulation of febuxostat pharmacokinetics in healthy subjects and patients with impaired kidney function using physiologically based pharmacokinetic modeling.
Topics: Febuxostat; Gout; Gout Suppressants; Healthy Volunteers; Humans; Kidney; Renal Insufficiency | 2022 |
Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency.
Topics: Adult; Bartter Syndrome; Chloride Channels; Diagnosis, Differential; Drug Therapy, Combination; Febuxostat; Female; Gitelman Syndrome; Gout Suppressants; Heterozygote; Humans; Hyperuricemia; Hypokalemia; Mutation; Phenotype; Potassium Chloride; Renal Insufficiency; Solute Carrier Family 12, Member 1; Treatment Outcome | 2020 |
Cost-effectiveness analysis of febuxostat in patients with gout in Spain.
Topics: Allopurinol; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Markov Chains; Models, Econometric; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Renal Insufficiency; Spain | 2016 |